Monoamine Oxidase Expression during Development and Aging

NeuroToxicology

Volumn 25, Issue 1-2, 2004, Pages 155-165

  Nicotra, Antonietta ^a   Pierucci, Federica ^a   Parvez, Hasan ^b   Senatori, Ornella ^a  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

^b CNRS   (France)

Author keywords

Aging; Development; Monoamine oxidase

Indexed keywords

AMINE OXIDASE (FLAVIN CONTAINING) ISOENZYME A; AMINE OXIDASE (FLAVIN CONTAINING) ISOENZYME B; MESSENGER RNA;

ADRENERGIC TRANSMISSION; AGING; AMPHIBIA; BIRD; BRAIN; BRAIN DEVELOPMENT; DATA ANALYSIS; DEVELOPMENTAL STAGE; ENZYME ACTIVITY; FETUS DEVELOPMENT; FISH; HUMAN; MONOAMINERGIC SYSTEM; MORPHOGENESIS; NERVE DEGENERATION; NONHUMAN; ONTOGENY; ORGANOGENESIS; PRIORITY JOURNAL; PROTEIN CONTENT; PROTEIN EXPRESSION; REGULATORY MECHANISM; REVIEW; VERTEBRATE;

AMPHIBIA; AVES; GYMNOMYZA; GYMNOMYZA SAMOENSIS; MAMMALIA; MUS MUSCULUS; RODENTIA; VERTEBRATA;

EID: 0346154810     PISSN: 0161813X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0161-813X(03)00095-0     Document Type: Article

References (112)

1. Arai Y, Kinemuchi H. Differences between MAO concentrations in striatum and forebrain of aged and young rats. J Neural Transm 1988;72:99-105.
2. Benedetti MS, Dostert P. Monoamine oxidase, brain aging and degenerative diseases. Biochem Pharmacol 1989;38:555-61.
3. Bennet-Clarke CA, Leslie MJ, Lane RD, Rhoades RW. Effect of serotonin depletion on vibrissa-related patterns of thalamic afferents in the rat's somatosensory cortex. J Neurosci 1994;14:7594-607.
4. Berry MD, Juorio AV, Paterson IA. The functional role of monoamine oxidases A and B in the mammalian central nervous system. Prog Neurobiol 1994;42:375-91.
5. Bourgoin S, Artaud F, Adrien J, Hery F, Glowinski J, Hamon M. 5-Hydroxytryptamine catabolism in the rat brain during ontogenesis. J Neurochem 1977;28:415-22.
6. Boylan CB, Bennet-Clarke CA, Crissman RS, Mooney RD, Rhoades RW. Clorgyline treatment elevates cortical serotonin and temporarily disrupts the vibrissae-related pattern in rat somatosensory cortex. J Comp Neurol 2000;427:139-49.
7. Brunet JE, Pattyn A. Phox2 genes from patterning to connectivity. Curr Opin Genet Dev 2002;12:435-40.
8. Buznikov GA. Neurotransmitters in embryogenesis. Chur, Switzerland: Harwood Academic Publishers, 1990.
9. Buznikov GA, Shmukler YB, Lauder JM. From oocyte to neuron: do neurotransmitters function in the same way throughout development? Cell Mol Neurobiol 1996;16:533-59.
10. Cao Danh H, Strolin Benedetti M, Dostert P. Differential changes in monoamine oxidase A and B activity in aging rat tissues. In: Tripton KF, Dostert P, Strolin Benedetti M, editors. Monoamine oxidase and disease. Prospects for therapy with reversible inhibitors. London: Academic Press, 1984. p. 301-17.
11. Carlo P, Violani E, Del Rio M, Olasmaa M, Santagati S, Maggi A, Picotti GB. Monoamine oxidase B expression is selectively regulated by dexamethasone in cultured rat astrocytes. Brain Res 1996;11:175-83.
12. Carlsson A. Aging and brain neurotransmitter. In: Platt D, editors. Funktionsstorungen des Gehirns im Alter. Schattauer: Stuttgart, 1981. p. 67-81.
13. Cases O, Vitalis T, Seif I, De Maeyer E, Sotelo C, Gaspar P. Lack of barrels in the somatosensory cortex of monoamine oxidase A-deficient mice: role of a serotonin excess during the critical period. Neuron 1996;16:297-307.
14. Castellano MA, Tortora JL, Selinke E. Histochemical studies on the monoamine oxidase during the development of the chick. Acta Histochem 1974;48S:132-48.
15. Chen K, Wu HF, Grimsby J, Shih JC. Cloning of a novel monoamine oxidase cDNA from trout liver. Mol Pharmacol 1994;46:1226-33.
16. Cvijic G, Radojicic R, Djordjevic J, Davidovic V. The effect of glucocorticoids on the activity of monoamine oxidase, copperzinc superoxide dismutase and catalase in the rat hypothalamus. Funct Neurol 1995;10:175-81.
17. Diez JA, Maderdrut JL. Development of multiple forms of mouse brain monoamine oxidase in vivo and in vitro. Brain Res 1977;128:187-92.
18. Ekblom J, Jossan SS, Bergstrom M, Oreland L, Walum E, Aquilonius S-M. Monoamine oxidase-B in astrocytes. Glia 1993;8:122-32.
19. Evans JM, Sinha AK, Pickard MR, Edwards PR, Leonard AJ, Ekins RP. Maternal hypothyroxinemia disrupts neurotransmitter metabolic enzymes in developing brain. J Endocrinol 1999;161:273-9.
20. Fahn S, Cohen G. The oxidant stress hypothesis in Parkinson's disease: evidence supporting it. Ann Neurol 1992;32:804-12.
21. Feirabend HKP. Development of longitudinal patterns in the cerebellum of the chicken (Gallus domesticus): a cytoarchitectural study on the genesis of the cerebellar modules. Eur J Morphol 1990;28:169-223.
22. Fiszman ML, Zuddas A, Masana MI, Barker JL, Di Porzio U. Dopamine synthesis precedes dopamine uptake in embryonic rat mesencephalic neurons. J Neurochem 1991;56:392-9.
23. Fowler CJ, Tipton KF. On the substrate specificities of the two forms of monoamine oxidase. J Pharm Pharmacol 1984;36:111-5.
24. Fowler CJ, Oreland L, Marcusson J, Winblad B. Titration of human brain monoamine oxidase A and B by clorgyline and L-deprenyl. Arch Pharmacol 1980a;311:263-72.
25. Fowler CJ, Wilberg A, Oreland L, Marcusson J, Winblad B. The effect of age on the activity and molecular properties of human brain monoamine oxidase. J Neural Transm 1980b;49:1-20.
26. Fowler JS, Volkow ND, Wang GJ, Logan J, Pappas N, Shea C, Mac-Gregor R. Age-related increases in brain monoamine oxidase B in living healthy human subjects. Neurobiol Aging 1997;18:431-5.
27. Fowler JS, Logan J, Wang GJ, Volkow ND. Monoamine oxidase and cigarette smoking. Neurotoxicology 2003;24:75-82.
28. Galva MD, Bondiolotti GP, Olasma M, Picotti GB. Effect of aging on lazabemide binding, monoamine oxidase activity and monoamine metabolites in human frontal cortex. J Neural Transm (Gen Sect) 1995;101:83-94.
29. Garrick NA, Murphy DL. Species differences in the deamination of dopamine and other substrates for monoamine oxidase in brain. Psychopharmacology 1980;72:27-33.
30. Gottfries CG. Neurochemical aspects on aging and diseases with cognitive impairement. J Neurosci Res 1990;27:541-57.
31. Gottfries CG, Oreland L, Wiberg A, Winblad B. Lowered monoamine oxidase activity in brains from alcoholic suicides. J Neurochem 1975;25:667-73.
32. Grimsby J, Lan NC, Neve R, Chen K, Shih JC. Tissue distribution of human monoamine oxidase A and B mRNA. J Neurochem 1990;55:1166-9.
33. Gripois D, Fernandez C. Effects of thyroid hormones on the evolution of monoamine oxidase activity in the brain and heart of the developing rat. Enzyme 1977;22:378-84.
34. Hall TR, Urueña G. Pharmacology and physiology of monoamine oxidase activity in vertebrates. A comparative study. Comp Biochem Physiol 1983;76:393-7.
35. Halliwell B. Reactive oxygen species and the central nervous system. J Neurochem 1992;59:1609-23.
36. Hanson SR, Mezey E, Hoffman BJ. Serotonin transporter messenger RNA in the developing brain: early expression in serotonergic neurons and transient expression in non serotonergic neurons. Neuroscience 1998;83:1185-201.
37. Holschneider DP, Kumazawa T, Chen K, Shih JC. Tissue-specific effects of estrogen on monoamine oxidase A and B in the rat. Life Sci 1998;63:155-60.
38. Holschneider DP, Chen K, Seif I, Shih JC. Biochemical, behavioral, physiologic, and neurodevelopmental changes in mice deficient in monoamine oxidase A e B. Brain Res Bull 2001;56:453-62.
39. Huttenlocher PR. Synaptic density in human frontal cortex-developmental changes and effects of aging. Brain Res 1979;163:195-205.
40. Ino M, Cole MG, Timiras SP. Tyrosine hydroxylase and monoamine oxidase A activity increases in differentiating human neuroblastoma after elimination of dividing cells. Dev Brain Res 1986;30:120-3.
41. Irwin I, Finnegan KT, DeLanney LE, Di Monte DA, Langston JW. The relationships between aging, monoamine oxidase, striatal dopamine and the effects of MPTP in C57BL/6 mice: a critical reassessment. Brain Res 1992;572:224-31.
42. Irwin I, Delanney L, Chan P, Sandy MS, Di Monte DA, Langston JW. Nigrostriatal monoamine oxidase A and B in aging squirrel monkeys and C57BL/6 mice. Neurobiol Aging 1997;18:235-41.
43. Jahng JW, Houpt TA, Wessel TC, Chen K, Shih JC, Joh TH. Localization of monoamine oxidase A and B mRNA in the rat brain by in situ hybridization. Synapse 1997;25:30-6.
44. Josson SS, Gillberg PG, Gottfries CG, Karlsson I, Oreland L. Monoamine oxidase B in brains from patients with Alzheimer's disease: a biochemical and autoradiographical study. Neuroscience 1991;145:1-12.
45. Jourdikian F, Tabakoff B, Alivisatos SGA. Ontogeny of multiple forms of monoamine oxidase in mouse brain. Brain Res 1975;93:301-8.
46. Kitahama K, Denney RM, Maeda T, Jouvet M. Distribution of type B monoamine oxidase immunoreactivity in the cat brain with reference to enzyme histochemistry. Neuroscience 1991;44:185-204.
47. Knoll J. The pharmacological basis of the beneficial effects of (-) deprenyl (selegiline) in Parkinson's and Alzheimer's diseases. J Neural Transm Suppl 1993;40:69-91.
48. Koide Y, Kobayashi K. Developmental changes in the activity and substrate specificities of mouse brain monoamine oxidase. Neurochem Res 1984;9:595-606.
49. Komhuber J, Konradi C, Mack-Burkhardt F, Riederer P, Heinsen H, Beckmann H. Ontogenesis of monoamine oxidase-A and -B in the human brain frontal cortex. Brain Res 1989;499:81-6.
50. Lee JJ, Chang CK, Liu IM, Chi TC, Yu HJ, Cheng JT. Changes in endogenous monoamines in aged rats. Clin Exp Pharmacol 2001;28:285-9.
51. Leung TKC, Lim L, Lai JCK. Brain regional distributions of monoamine oxidase activities in postnatal development in normal and chronically manganese-treated rats. Metab Brain Dis 1993;8:137-49.
52. Levitt P, Maxwell GD, Pintar JE. Specific cellular expression of monoamine oxidase B during early stages of quail embryogenesis. Dev Biol 1985;110:346-61.
53. Levitt P, Harvey JA, Friedman E, Simansky K, Murphy EH. New evidence for neurostransmitter influences on brain development. Trends Neurosci 1997;20:269-74.
54. Lewinsohn R, Glover V, Sandler M. Development of benzylamine oxidase and monoamine oxidase A and B in man. Biochem Pharmacol 1980;29:1221-30.
55. Liu KP, Tamir H, Hsiung S, Adlersberg M, Gershon MD. Prenatal development of serotonin binding protein in relation to other transmitter related characteristics of central serotoninergic neurons. Dev Brain Res 1987;32:31-41.
56. Luque JM, Kwan SW, Abell CW, Da Prada M, Richards JG. Cellular expression of mRNAs encoding monoamine oxidase A and B in the rat central nervous system. J Comp Neurol 1995;363:665-80.
57. Lyles GA, Callingham BA. Selective influences of age and thyroid hormones on type A monoamine oxidase of the rat heart. J Pharm Pharmacol 1979;31:755-60.
58. Mantle TJ, Garret NJ, Tipton KF. The development of monoamine oxidase in rat liver and brain. FEBS Lett 1976;64:227-30.
59. Means AL, Gudas LJ. The roles of retinoids in vertebrate development. Annu Rev Biochem 1995;64:201-33.
60. Melamed E, Rosenthal J, Youdim MBH. Immunity of fetal mice to prenatal administration of the dopaminergic neutotoxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine. J Neurochem 1990;55:1427-31.
61. Nakamura S, Kawamata T, Akiguchi I, Kameyama M, Nakamura N, Kimura H. Expression of monoamine oxidase B activity in astrocytes of senile plaques. Acta Neuropathol 1990;80:319-25.
62. Nicotra A, Senatori O. Occurrence of type A and type B monoamine oxidase activities in toad egg mitochondria. Comp Biochem Physiol 1984;78C:353-6.
63. Nicotra A, Senatori O. Changes in monoamine oxidase activity by mitochondria isolated from late embryos of Bufo bufo. Comp Biochem Physiol 1988;89C:5-9.
64. Nicotra A, Senatori O. Some characteristics of mitochondrial monoamine oxidase activity in eggs of carp (Cyprinus carpio) and rainbow trout (Salmo gairdneri). Comp Biochem Physiol 1989;92C:401-4.
65. Nicotra A, Schatten G. Propranolol, a β-adrenergic receptor blocker, affects microfilament organization, but not microtubules during the first division in sea urchin eggs. Cell Motility Cytoskel 1990;16:182-9.
66. Nicotra A, Serafino AL, Arizzi M. Deprenyl, an inhibitor of monoamine oxidase B, delays the first two mitotic cycles of sea urchin eggs. Dev Growth Differ 1989;31:17-21.
67. Nicotra A, Senatori O, Parvez SH. Ontogeny of monoamine oxidase A and B activities in developing chick cerebellum: a biochemical study. Biog Amines 2000;15:489-501.
68. Nicotra A, Falasca L, Senatori O, Conti Devirgiliis L. Monoamine oxidase A and B activities in embryonic chick hepatocytes: differential regulation by retinoic acid. Cell Biochem Funct 2001;19:1-8.
69. Oreland L, Gottfries GC. Brain and brain monoamine oxidase in aging and in dementia of Alzheimer's type. Prog Neuropsychopharmacol Biol Psychiatr 1986;10:533-40.
70. Pardon MC, Joubert C, Perez-Diaz F, Christen Y, Launay JM, Cohen-Salmon C. In vivo regulation of cerebral monoamine oxidase activity in senescent controls and chronically stressed mice by long-term treatment with Ginko biloba extract (EGb 761). Mech Ageing Dev 2000;113:157-68.
71. Pattyn A, Goridis C, Brunet JF. Specification of the central noradrenergic phenotype by the homeobox gene Phox2b. Mol Cell Neurosci 2000;15:235-43.
72. Pfohl B, Sherman B, Schlechte J, Stone R. Pituitary-adrenal axis rhythm disturbances in psychiatric depression. Arch Gen Psychiatry 1985;42:897-903.
73. Pintar JE, Maxwell GD, Breakefield XO. Characterization of monoamine oxidase activity during early stages of quail embryogenesis. Int J Dev Neurosci 1983;1:49-57.
74. Ponzio F, Calderini G, Lomuscio G, Vantini G, Toffano G, Algeri S. Changes in monoamines and their metabolite levels in some brain regions of aged rats. Neurobiol Aging 1982;3:23-9.
75. Rao KM, Nagendra SN, Subhash MN. Monoamine oxidase isoenzymes in rat brain: differential changes during postnatal development but not aging. Neurobiol Aging 1995;16:833-6.
76. Robinson DS. Changes in monoamine oxidase and monoamines with human development and aging. Fed Proc 1975;34:103-7.
77. 2 with monoamine oxidase B sites. J Neurochem 1993;61:881-9.
78. Saura J, Richards JG, Mahy N. Differential age-related changes of MAO-A and MAO-B in mouse brain and peripheral organs. Neurobiol Aging 1994a;15:399-408.
79. Saura J, Luque AM, Cesura M, Da Prada M, Chan-Palay V, Huber G, Loeffler J, Richards JG. Increased monoamine oxidase B activity in plaque-associated astrocytes of Alzheimer brains revealed by quantitative enzyme radioautography. Neuroscience 1994b;62:15-30.
80. Saura J, Andrés N, Andrade C, Ojuel J, Eriksson K, Mahy N. Biphasic and region-specific MAO B response to aging in normal human brain. Neurobiol Aging 1997;18:497-507.
81. Scanes CG, Decuypere E, Khun ER. Endocrinology of the avian embryo: an overview. J. Exp. Zool. 1987(suppl. 1):253-264.
82. Senatori O, Nicotra A. Developmental changes in monoamine oxidase activity towards serotonin in chick heart and liver. Biog Amines 1997;13:181-93.
83. Senatori O, Nicotra A, Scopelliti R. Monoamine oxidase activity in embryos of pike (Esox lucius). Comp Biochem Physiol 1990;96C:87-90.
84. Shemyakov SE. Monoamine oxidase activity, lipid peroxidation, and morphological changes in human hypothalamus during aging. Bull Exp Biol Med 2001;131:694-6.
85. Sherif F, Gottfries CG, Alafuzoff I, Oreland L. Brain γ-aminobutyrate aminotransferase (GABA-T) and monoamine oxidase (MAO) in patients with Alzheimer's disease. J Neural Transm (P-D Sect) 1992;4:227-40.
86. Shih JC. Monoamine oxidase in aging human brain. In: Singer TP, Von Korff RW, Murphy DL, editors. Monoamine oxidase: structure, function and altered functions. New York: Academic Press, 1979. p. 413-21.
87. Shuey DL, Sadler TW, Tamir H, Lauder JM. Serotonin and morphogenesis. Anat Embryol 1993;187:75-85.
88. Sparks DL, Woeltz VM, Markesbery WR. Alterations in brain monoamine oxidase activity in aging, Alzheimer's disease, and Pick's disease. Arch Neurol 1991;48:718-21.
89. Slotkin TA, Seidler FJ, Ritchie JC. Effects of aging and glucocorticoid treatment on monoamine oxidase subtypes in rat cerebral cortex: therapeutic implications. Brain Res Bull 1998;47:345-8.
90. Srivastava N, Grove J, Vernadakis A. Astrocyte differentiation is enhanced in chick embryos treated with ethanol during early neuroembryogenesis. Neurochem Res 1995;20:985-9.
91. Strolin Benedetti M, Keane PE. Differential changes in monoamine oxidase A and B activity in the aging rat brain. J Neurochem 1980;35:1026-32.
92. Strolin Benedetti M, Dostert P, Tipton KF. Developmental aspects of the monoamine-degrading enzyme monoamine oxidase. Dev Pharmacol Ther 1992;18:191-200.
93. Suzuki O, Yagi K. Distribution of type A and B monoamine oxidase activities in the central nervous system of rat and chick. Experientia 1976;32:13-4.
94. Suzuki O, Naguchi E, Yagi K. Monoamine oxidase in developing chick retina. Brain Res 1977;135:305-13.
95. Tipton KF, Singer TP. Advances in our understanding of the mechanisms of neurotoxicity of MPTP and related compounds. J Neurochem 1993;61:1191-206.
96. Tsai CL, Wang LH. Effects of gonadal steroids on the serotonin synthesis and metabolism in the early developing tilapia brain. Neurosci Lett 1999;264:45-8.
97. Venero JL, De la Roza C, Machado A, Cano J. Age-related changes on monoamine turnover in hippocampus of rats. Brain Res 1993;631:89-96.
98. Virgili M, Saverino O, Vaccari M, Barnabei O, Contestabile A. Temporal, regional and cellular selectivity of neonatal alteration of the thyroid state on neurochemical maturation in the rat. Exp Brain Res 1991;83:555-61.
99. Vitalis T, Cases O, Callebert J, Launay JM, Price DJ, Seif I, Gaspar P. Effects of monoamine oxidase A inhibition on barrel formation in the mouse somatosensory cortex: determination of a sensitive developmental period. J Comp Neurol 1998;393:169-84.
100. Vitalis T, Fouquet C, Alvarez C, Seif I, Price D, Gaspar P, Cases O. Developmental expression of monoamine oxidases A and B in the central and peripheral nervous systems of the mouse. J Comp Neurol 2002;442:331-47.
101. Vizuete ML, Santiago M, Herrera AJ, Venero JL, Machado A, Cano J. Effects of neonatal bilateral eye enucleation on postnatal development of the monoamines in posterior thalamus of the rat. J Neural Transm 1991;85:231-42.
102. Volchegorskii IA, Shemyakov SE, Turygin VV, Malinovskaya NV. Comparative analysis of age-related changes in activities of monoamine oxidase-B and antioxidant defense enzymes in various structures of human brain. Bull Exp Biol Med 2001;132:174-7.
103. Wee EL, Zimmerman EF. Involvment of GABA in palate morphogenesis and its relation to diazepam teratogenesis in two mouse strains. Teratology 1983;28:15-22.
104. Wallace JA. Monoamines in the early chick embryo: demonstration of serotonin synthesis and the regional distribution of serotonin concentrating cells during morphogenesis. Am J Anat 1982;165:261-76.
105. Weyler W, Hsu YP, Breakefield XO. Biochemistry and genetics of monoamine oxidase. Pharmacol Ther 1990;47:391-417.
106. Whitaker-Azmitia PM, Zhang X, Clarke C. Effects of gestational exposure to monoamine oxidase inhibitors in rats: preliminary behavioral and neurochemical studies. Neuropsychopharmacol 1994;11:125-32.
107. Yavarone MS, Shuey DL, Tamir H, Sadler TW. Serotonin and cardiac morphogenesis in the mouse embryo. Teratology 1993;47:573-84.
108. Yew DT, Chan WY. Early appearance of acetylcholinergic, serotoninergic, and peptidergic neurons and fibers in the developing human central nervous system. Microsc Res Technol 1999;45:389-400.
109. Yoshino M, Obata T, Sho S, Kinemuchi H. Enzymic and molecular characteristics of a new form of monoamine oxidase, distinct from A and B form. Jpn. J. Pharmacol. 1984;105-115.
110. Youdim MBH, Finberg JPM, Tipton KF. Monoamine oxidase. In: Trendelenburg U, Weiner N, editors. Handbook of Experimental Pharmacology. Berlin: Springer, 1988. p. 119-92.
111. Yurkewicz L, Marchi M, Lauder JM, Giacobini E. Development and aging of noradrenergic cell bodies and axon terminals in the chicken. J Neurosci Res 1981;6:621-41.
112. Zhu Q-S, Grimsby J, Chen K, Shih JC. Promoter organization and activity of human monoamine oxidase (MAO) A and B genes. J Neurosci 1992;12:4437-46.